213 related articles for article (PubMed ID: 25186551)
1. Exposure to antidepressants during pregnancy--prevalences and outcomes.
Jimenez-Solem E
Dan Med J; 2014 Sep; 61(9):B4916. PubMed ID: 25186551
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn].
Favrelière S; Nourrisson A; Jaafari N; Pérault Pochat MC
Encephale; 2010 Jun; 36 Suppl 2():D133-8. PubMed ID: 20513456
[TBL] [Abstract][Full Text] [Related]
3. Exposure to duloxetine during pregnancy and risk of congenital malformations and stillbirth: A nationwide cohort study in Denmark and Sweden.
Ankarfeldt MZ; Petersen J; Andersen JT; Li H; Motsko SP; Fast T; Hede SM; Jimenez-Solem E
PLoS Med; 2021 Nov; 18(11):e1003851. PubMed ID: 34807906
[TBL] [Abstract][Full Text] [Related]
4. Maternal use of selective serotonin reuptake inhibitors and risk of congenital malformations.
Wogelius P; Nørgaard M; Gislum M; Pedersen L; Munk E; Mortensen PB; Lipworth L; Sørensen HT
Epidemiology; 2006 Nov; 17(6):701-4. PubMed ID: 17028507
[TBL] [Abstract][Full Text] [Related]
5. Selective serotonin reuptake inhibitors during pregnancy and risk of stillbirth and infant mortality.
Stephansson O; Kieler H; Haglund B; Artama M; Engeland A; Furu K; Gissler M; Nørgaard M; Nielsen RB; Zoega H; Valdimarsdóttir U
JAMA; 2013 Jan; 309(1):48-54. PubMed ID: 23280224
[TBL] [Abstract][Full Text] [Related]
6. Pregnancy outcome after exposure to antidepressants and the role of maternal depression: results from the Norwegian Mother and Child Cohort Study.
Nordeng H; van Gelder MM; Spigset O; Koren G; Einarson A; Eberhard-Gran M
J Clin Psychopharmacol; 2012 Apr; 32(2):186-94. PubMed ID: 22367660
[TBL] [Abstract][Full Text] [Related]
7. SSRI antidepressants and birth defects.
Prescrire Int; 2006 Dec; 15(86):222-3. PubMed ID: 17167929
[TBL] [Abstract][Full Text] [Related]
8. Antidepressant use during pregnancy and the risk of major congenital malformations in a cohort of depressed pregnant women: an updated analysis of the Quebec Pregnancy Cohort.
Bérard A; Zhao JP; Sheehy O
BMJ Open; 2017 Jan; 7(1):e013372. PubMed ID: 28082367
[TBL] [Abstract][Full Text] [Related]
9. Delivery outcome after maternal use of antidepressant drugs in pregnancy: an update using Swedish data.
Reis M; Källén B
Psychol Med; 2010 Oct; 40(10):1723-33. PubMed ID: 20047705
[TBL] [Abstract][Full Text] [Related]
10. Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressants in Pregnancy and Congenital Anomalies: Analysis of Linked Databases in Wales, Norway and Funen, Denmark.
Jordan S; Morris JK; Davies GI; Tucker D; Thayer DS; Luteijn JM; Morgan M; Garne E; Hansen AV; Klungsøyr K; Engeland A; Boyle B; Dolk H
PLoS One; 2016; 11(12):e0165122. PubMed ID: 27906972
[TBL] [Abstract][Full Text] [Related]
11. First trimester exposure to paroxetine and risk of cardiac malformations in infants: the importance of dosage.
Bérard A; Ramos E; Rey E; Blais L; St-André M; Oraichi D
Birth Defects Res B Dev Reprod Toxicol; 2007 Feb; 80(1):18-27. PubMed ID: 17187388
[TBL] [Abstract][Full Text] [Related]
12. Maternal Use of Specific Antidepressant Medications During Early Pregnancy and the Risk of Selected Birth Defects.
Anderson KN; Lind JN; Simeone RM; Bobo WV; Mitchell AA; Riehle-Colarusso T; Polen KN; Reefhuis J
JAMA Psychiatry; 2020 Dec; 77(12):1246-1255. PubMed ID: 32777011
[TBL] [Abstract][Full Text] [Related]
13. Pregnancy outcomes following use of escitalopram: a prospective comparative cohort study.
Klieger-Grossmann C; Weitzner B; Panchaud A; Pistelli A; Einarson T; Koren G; Einarson A
J Clin Pharmacol; 2012 May; 52(5):766-70. PubMed ID: 22075232
[TBL] [Abstract][Full Text] [Related]
14. Delivery outcome in relation to maternal use of some recently introduced antidepressants.
Lennestål R; Källén B
J Clin Psychopharmacol; 2007 Dec; 27(6):607-13. PubMed ID: 18004128
[TBL] [Abstract][Full Text] [Related]
15. SSRI use during pregnancy and risk of stillbirth and neonatal mortality.
Jimenez-Solem E; Andersen JT; Petersen M; Broedbaek K; Lander AR; Afzal S; Torp-Pedersen C; Poulsen HE
Am J Psychiatry; 2013 Mar; 170(3):299-304. PubMed ID: 23361562
[TBL] [Abstract][Full Text] [Related]
16. Selective serotonin reuptake inhibitor exposure during early pregnancy and the risk of fetal major malformations: focus on paroxetine.
Gentile S; Bellantuono C
J Clin Psychiatry; 2009 Mar; 70(3):414-22. PubMed ID: 19254517
[TBL] [Abstract][Full Text] [Related]
17. Risks of congenital malformations and perinatal events among infants exposed to antidepressant medications during pregnancy.
Davis RL; Rubanowice D; McPhillips H; Raebel MA; Andrade SE; Smith D; Yood MU; Platt R;
Pharmacoepidemiol Drug Saf; 2007 Oct; 16(10):1086-94. PubMed ID: 17729378
[TBL] [Abstract][Full Text] [Related]
18. Selective serotonin reuptake inhibitor use during early pregnancy and congenital malformations: a systematic review and meta-analysis of cohort studies of more than 9 million births.
Gao SY; Wu QJ; Sun C; Zhang TN; Shen ZQ; Liu CX; Gong TT; Xu X; Ji C; Huang DH; Chang Q; Zhao YH
BMC Med; 2018 Nov; 16(1):205. PubMed ID: 30415641
[TBL] [Abstract][Full Text] [Related]
19. Antidepressant use in pregnancy and severe cardiac malformations: Danish register-based study.
Kolding L; Ehrenstein V; Pedersen L; Sandager P; Petersen OB; Uldbjerg N; Pedersen LH
BJOG; 2021 Nov; 128(12):1949-1957. PubMed ID: 34036715
[TBL] [Abstract][Full Text] [Related]
20. Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression.
Nulman I; Koren G; Rovet J; Barrera M; Pulver A; Streiner D; Feldman B
Am J Psychiatry; 2012 Nov; 169(11):1165-74. PubMed ID: 23128923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
